Funding of US Biomedical Research, 2003-2008

CONTEXT With the exception of the American Recovery and Reinvestment Act, funding support for biomedical research in the United States has slowed after a decade of doubling. However, the extent and scope of slowing are largely unknown. OBJECTIVE To quantify funding of biomedical research in the Unit...

Full description

Saved in:
Bibliographic Details
Published in:JAMA : the journal of the American Medical Association 2010-01, Vol.303 (2), p.137-143
Main Authors: Dorsey, E. Ray, de Roulet, Jason, Thompson, Joel P, Reminick, Jason I, Thai, Ashley, White-Stellato, Zachary, Beck, Christopher A, George, Benjamin P, Moses, Hamilton
Format: Article
Language:English
Subjects:
Biological and medical sciences
Biomedical research
Biomedical Research - economics
Device Approval
Financing, Government - trends
Funding
General aspects
Health Policy - economics
Health Services Research - economics
Industry - economics
Inflation
Local Government
Medical sciences
Miscellaneous
National Institutes of Health (U.S.)
Public health. Hygiene
Public health. Hygiene-occupational medicine
Regression Analysis
Research Support as Topic - trends
State Government
United States
United States Food and Drug Administration
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:CONTEXT With the exception of the American Recovery and Reinvestment Act, funding support for biomedical research in the United States has slowed after a decade of doubling. However, the extent and scope of slowing are largely unknown. OBJECTIVE To quantify funding of biomedical research in the United States from 2003 to 2008. DESIGN Publicly available data were used to quantify funding from government (federal, state, and local), private, and industry sources. Regression models were used to compare financial trends between 1994-2003 and 2003-2007. The numbers of new drug and device approvals by the US Food and Drug Administration over the same period were also evaluated. MAIN OUTCOME MEASURES Funding and growth rates by source; numbers of US Food and Drug Administration approvals. RESULTS Biomedical research funding increased from $75.5 billion in 2003 to $101.1 billion in 2007. In 2008, funding from the National Institutes of Health and industry totaled $88.8 billion. In 2007, funding from these sources, adjusted for inflation, was $90.2 billion. Adjusted for inflation, funding from 2003 to 2007 increased by 14%, for a compound annual growth rate of 3.4%. By comparison, funding from 1994 to 2003 increased at an annual rate of 7.8% (P 
ISSN:0098-7484
1538-3598
DOI:10.1001/jama.2009.1987